US Patent 9102735 Immunoconjugates with an intracellularly-cleavable linkage
Patent 9102735 was granted and assigned to IMMUNOMEDICS, INC. on August, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+304 characters)
Article
Patent abstract
The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates.
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09102735 Immunoconjugates with an intracellularly-cleavable linkage US Patent 9102735 Immunoconjugates with an intracellularly-cleavable linkage
Infobox
Patent Number
091027350
Patent Number
91027350
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
091027350
Date of Patent
August 11, 2015
0Patent Application Number
140482220
Date Filed
October 8, 2013
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09102735 Immunoconjugates with an intracellularly-cleavable linkage
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09102735
Date of patent
August 11, 2015
Patent application number
14048222
Date Filed
October 8, 2013
Patent primary examiner
Find more entities like US Patent 9102735 Immunoconjugates with an intracellularly-cleavable linkage
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
